New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii.
D000818:Animals; D015195:Drug Design; D006801:Humans; D007165:Immunosuppression Therapy; D015394:Molecular Structure; D009894:Opportunistic Infections / Q000188:drug therapy* / Q000503:physiopathology; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy* / Q000503:physiopathology; D013329:Structure-Activity Relationship